Bayhealth Medical Center Hematology and Medical Oncology

Topics

• Acute Myeloid Leukemia Research 93
• Hematopoietic Stem Cell Transplantation 87
• Lymphoma Diagnosis and Treatment 46
• Cancer Immunotherapy and Biomarkers 21
• Immune Cell Function and Interaction 14
• Occupational and environmental lung diseases 13
• Platelet Disorders and Treatments 12
• Chronic Lymphocytic Leukemia Research 11
• Complement system in diseases 10
• Multiple Myeloma Research and Treatments 10
• Neutropenia and Cancer Infections 10
• Acute Lymphoblastic Leukemia research 9

Most cited

1. Menin Inhibition With Revumenib for KMT2A-Rearranged Relapsed or Refractory Acute Leukemia (AUGMENT-101).

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2025 · 213 citations · Christine McMahon

2. A decade of checkpoint blockade immunotherapy in melanoma: understanding the molecular basis for immune sensitivity and resistance.

   Nature immunology · 2022 · 482 citations · Alexander Huang

3. Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients.

   Science (New York, N.Y.) · 2024 · 202 citations · Alexander Huang

4. CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer.

   Nature medicine · 2021 · 433 citations · Alexander Huang

5. Pathological response and survival with neoadjuvant therapy in melanoma: a pooled analysis from the International Neoadjuvant Melanoma Consortium (INMC).

   Nature medicine · 2021 · 379 citations · Alexander Huang

6. Menin inhibition with revumenib for NPM1-mutated relapsed or refractory acute myeloid leukemia: the AUGMENT-101 study.

   Blood · 2025 · 67 citations · Christine McMahon